Yale-Drug use, Addiction, and HIV prevention Research Scholars (Yale-DAHRS)

7.项目摘要/摘要 我们要求第二次续签我们为期5年的耶鲁大学药物使用、成瘾和艾滋病毒预防研究奖学金 (耶鲁-DAHRS)计划，一直为以下人员提供密集的研究培训和职业发展 自2013年以来专注于医疗环境研究的内科科学家(学者)，具有较高的影响力 结果。耶鲁-DAHRS项目已经成功地招募了10名不同的学者(7名女性和2名乌里姆) 代表多个医生学科，包括急诊医学、普通内科 医学/艾滋病毒/肝病/肺科、儿科/青春期医学和妇产科， 涵盖各种医疗环境和人群中的患者生命周期。有成瘾前期的患者 物质使用障碍通常会因一系列复杂的急性后果而接受医疗护理 急诊科等医疗环境中药物使用的并发症和慢性疾病 以及初级保健和专科诊所。耶鲁-DAHRS项目提供了一个全面的三年后- 博士学位，跨学科指导的职业发展计划，纳入了强有力的教学 获得健康科学硕士学位的研究课程，有指导的研究和专题培训 与成瘾医学相关：[目标1]培养具有以下知识和技能的内科科学家 成为独立的调查人员，产生新的发现来改善药物使用和成瘾的结果 通过在医疗环境中进行预防和治疗。[目标2]通过提供学者培养未来的领导者 有能力确保成功领导多学科团队研究药物使用的预防和治疗 和成瘾及其实施和融入医疗环境；以及[目标3]加强 毒品使用和成瘾研究人员的多样性，并在所有阶段大力解决卫生公平问题 上瘾研究。谈女性和乌里姆教职员工在内科科学家中的代表性 员工队伍将增强调查人员和研究主题的多样性，拓宽背景和视角 研究重点，增加试验参与度，扩大知识面。我们的节目已经取得了成功 利用耶鲁大学和我们的社区合作伙伴已建立的培训和临床项目的协同效应， 以及我们经验丰富、多样化的跨学科核心教师、导师和 咨询委员会。我们的毕业生都在教师研究的轨道上，在他们的 各自的字段。其中七人在成瘾医学学院学习。他们出版并传播了他们的 研究成果广泛，而且都是联邦政府资助的。此次续签将继续支持2名现役学者 并将支持3名新的学者。拟议的续订受益于对耶鲁-DAHRS的迭代更改 随着时间的推移，包括增加正式的领导力培训/指导和新的解决方案 研究中的多样性、公平性和包容性，以确定差异和干预措施，以改善患者结果。

7. Project Summary/Abstract We request a 2nd renewal for our 5-year Yale Drug use, Addiction and HIV prevention Research Scholars (Yale-DAHRS) program which has been providing intensive research training and career development for physician scientists (scholars) focusing on research in medical settings since 2013 with high impact results. The Yale-DAHRS program has successfully recruited 10 diverse scholars (7 women and 2 URiM) representing multiple physician disciplines, including Emergency Medicine, General Internal Medicine/HIV/Hepatology/Pulmonary, Pediatrics/Adolescent Medicine and Obstetrics and Gynecology, covering the patient life span in a wide range of medical settings and populations. Patients with pre-addiction and substance use disorders often receive medical care for a complex array of acute consequences and complications of substance use and chronic conditions in medical settings such as emergency departments and primary care and specialty clinics. The Yale-DAHRS program provides a comprehensive three-year post- doctorate, interdisciplinary Mentored Career Development Program that incorporates a robust didactic research curriculum leading to a Masters in Health Science degree, mentored research and training in topics related to Addiction Medicine to: [Aim 1] Develop physician scientists with the knowledge and skills to become independent investigators, generating novel findings to improve drug use and addiction outcomes through prevention and treatment in medical settings. [Aim 2] Develop future leaders by providing scholars with skills to ensure success in leading multidisciplinary teams in studying prevention & treatment of drug use and addiction and their implementation and integration into medical settings; and [Aim 3] Enhance the diversity of drug use and addiction researchers, and robustly address health equity in all stages of addiction research. Addressing the representation of women and URiM faculty in the physician scientist workforce will enhance the diversity of investigators and research topics, broaden perspectives in setting research priorities, increase trial participation, and expand knowledge. Our program has demonstrated success capitalizing on the synergies of established training and clinical programs at Yale and our community partners, and the experiences offered by our seasoned, diverse group of interdisciplinary core faculty, mentors and advisory committee. Our graduates are all on faculty research tracks, and recognized leaders in their respective fields. Seven are boarded in Addiction Medicine. They have published and disseminated their research findings widely, and are all federally funded. This renewal will continue support for 2 current scholars and will also support 3 new scholars. The proposed renewal benefits from iterative changes to Yale-DAHRS over time including the addition of formal leadership training/coaching and new approaches to addressing diversity, equity and inclusion in research to identify disparities and interventions to improve patient outcomes.